Results 111 to 120 of about 1,107,574 (309)
Studying the Effect of Alpha-Tocopherol on Cell Proliferation and Apoptosis in Rat Bone Marrow Mesenchymal Stem Cells [PDF]
Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk, 2015 Background: Alpha-tocopherol, as a strong antioxidant, plays an important role in testraining free radicals. The aim of this study was to investigate the effect of Alpha-tocopherol on cell proliferation and restraining apoptosis in rat bone marrow ...
Malek Soleimani Mehranjani +2 more
doaj
Dietary Phosphorus Requirement for Tambaqui, Colossoma macropomum, in the Grow‐Out Phase
Journal of Animal Physiology and Animal Nutrition, EarlyView.ABSTRACT Phosphorus is essential for fish growth as it is crucial in skeletal development and metabolic reactions. The dietary requirement for this mineral varies among fish species and growth stages. Therefore, the objective of this study was to determine the available phosphorus (AP) requirement for tambaqui during the grow‐out phase (± 400 to 1000 g)
Ludmila L. C. Menezes +5 more
wiley +1 more source
Journal of Ardabil University of Medical Sciences, 2017 Background & objectives: Ischemic stroke has complex pathophysiology and its treatment with single neuroprotective drugs has so far failed. Combination therapy could produce amplified protective effects via different mechanisms.
Hamdollah Panahpour, Adel Haghnejad Azar
doaj
Systemic, Lifestyle and Environmental Modifying Factors in the Pathogenesis of Periodontitis
Journal of Periodontal Research, EarlyView.A variety of impacting factors in the pathogenesis of periodontitis exist, including systemic, lifestyle, and environmental factors. This review highlights the manifold mechanistic aspects of the link between the pathogenesis of periodontitis, addressing these numerous factors to supplement the long‐standing knowledge of the progression of the disease.
Groeger Sabine Elisabeth +5 more
wiley +1 more source
The First Physiologically Based Pharmacokinetic (PBPK) Model for an Oral Vaccine Using Alpha-Tocopherol as an Adjuvant. [PDF]
Pharmaceutics, 2023 Saldanha L, Vale N.
europepmc +1 more source
New Insights Into Diffuse Sclerosing Osteomyelitis: Is There a Role of ANA and Vitamin B6?
Oral Diseases, EarlyView.ABSTRACT Object Diffuse sclerosing osteomyelitis is a poorly understood chronic disease, which appears predominantly in the mandible. Female patients are more often affected than men. DSO is an ultra‐rare disease and incidence is unknown; diagnosis can be very challenging; pathogenesis is poorly understood.
Katharina Theresa Obermeier +6 more
wiley +1 more source
Angewandte Chemie, Volume 137, Issue 32, August 4, 2025.The sequential functionalization of novel BCP‐substituted ethynylbenziodoxolone (EBX) reagents into heteroatom‐ and BCP‐substituted alkenes is described. The addition of N, O, and S nucleophiles on the EBXs was stereoselective and generated heteroatomic Z‐vinylbenziodoxolone (VBX) reagents.
Najung Lee +3 more
wiley +2 more sources
Plant Biotechnology Journal, EarlyView.Summary Saffron apocarotenoids, including crocins, picrocrocin and safranal, are valuable metabolites with pharmaceutical and cosmetic potential. However, their natural plant sources are difficult to cultivate, which limits large‐scale production. The identification of carotenoid cleavage dioxygenases (CCDs), which catalyse the first and most critical ...
Maria Lobato‐Gómez +6 more
wiley +1 more source
Polo‐like kinases and UV‐induced skin carcinogenesis: What we know and what's next
Photochemistry and Photobiology, EarlyView.The polo‐like kinase (PLK) family plays distinct and critical roles in the regulation of cell cycle progression, and its dysregulation has been implicated in various cancers. Ultraviolet (UV) radiation is a well‐established environmental factor in the development of skin cancer.
Tanya Jaiswal +3 more
wiley +1 more source
Journal of Lipid Research, 1991 Twelve clinically healthy subjects participated in a vitamin E supplementation study. Eight were given daily dosages of 150, 225, 800, or 1200 IU RRR-alpha-tocopherol for 21 days (two persons per dose) and four received placebo.
M Dieber-Rotheneder +4 more
doaj